Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ
This study has been completed.
Study NCT00567164   Information provided by Bayer

First Received on December 3, 2007.   Last Updated on September 19, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Contraception
Ovulation Inhibition
Contraceptives, Oral
Interventions listed in this trial
EE20/DRSP (BAY86-5300)
EE20/DRSP (YAZ, BAY86-5300)
Additional drug interventions recognized in this trial
Contraceptive Agents
Contraceptives, Oral
Drospirenone
Drospirenone and ethinyl estradiol combination
Ethinyl Estradiol
More general drug interventions related to this trial
Aldosterone Antagonists
Contraceptive Agents, Female
Estrogens
Hormone Antagonists
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Bayer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services